Showing results (401-410 of 434) with videos related to

Sort By:
Pageof 44
Antimicrobial Agents and Chemotherapy|January 16, 2019
Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202Cindy J Bednasz, Charles S Venuto, Qing Ma, et al.
Pharmacogenetics and Genomics|May 31, 2018
Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse eventsDavid W Haas, Yuki Bradford, Anurag Verma, et al.
Pharmacogenetics and Genomics|October 20, 2012
Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variantsEmily R Holzinger, Benjamin Grady, Marylyn D Ritchie, et al.
The American Journal on Addictions|December 7, 2007
Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavirNiamh Higgins, Barry S Zingman, Judianne Slish, et al.
Antimicrobial Agents and Chemotherapy|September 23, 2015
Artemether-Lumefantrine Exposure in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral TherapySunil Parikh, Fatai Fehintola, Liusheng Huang, et al.
Molecules (Basel, Switzerland)|June 20, 2019
Microbiological Evaluation of 5 L- and 20 L-Transparent Polypropylene Buckets for Solar Water Disinfection (SODIS)M Inmaculada Polo-López, Azahara Martínez-García, Maria Jesus Abeledo-Lameiro, et al.
Journal of Public Health in Africa|April 8, 2020
Mentored postdoctoral training in Zimbabwe: A report on a successful collaborative effortDanai T Zhou, Charles C Maponga, Munyaradzi Madhombiro, et al.
AIDS Research and Treatment|April 14, 2012
Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian AdultsFatai A Fehintola, Kimberly K Scarsi, Qing Ma, et al.
Pageof 44